AIM ImmunoTech (AIM) said Tuesday it received a noncompliance notice from NYSE American for failing to meet continued listing requirements.
The company said it was notified about noncompliance with the minimum required stockholders' equity for a company that has reported losses from continuing operations and net losses in its five most recent fiscal years.
AIM said the notice has no immediate impact on its listing status and does not affect its business operations or its reporting requirements with the US Securities and Exchange Commission.
The company said it has until Jan. 10 to submit a plan to regain compliance.
Shares of the company were down nearly 5% in recent after-hours activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。